Figure 3.

Survival curves of patients with COVID19-associated invasive fungal diseases. Kaplan Meier survival curves are shown for (A) patients with invasive candidiasis (red) and pulmonary mold disease (blue); (B) pulmonary mold disease, treated with extended-spectrum azole (brown) versus control (purple); Cox regression survival curves are shown for patients with invasive candidiasis (C,D), comparing treatment effects of (C) fluconazole (red) versus control (green); and (D) echinocandin (red) versus control (green).